Steven Durrant

Person

Abingdon, GB

People

Patents Grantslast 30 patents

Information Patent Grant
N-(hydroxyalkyl (hetero)aryl) tetrahydrofuran carboxamides as modul...
- Patent number 12,258,333
- Issue date Mar 25, 2025
- Vertex Pharmaceuticals Incorporated
- Elizabeth Mary Beck
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Substituted tetrahydrofurans as modulators of sodium channels
- Patent number 12,247,021
- Issue date Mar 11, 2025
- Vertex Pharmaceuticals Incorporated
- Steven John Durrant
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Compounds useful as inhibitors of ATR kinase
- Patent number 12,187,731
- Issue date Jan 7, 2025
- Vertex Pharmaceuticals Incorporated
- Nadia Ahmad
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
GCN2 inhibitors and uses thereof
- Patent number 12,084,438
- Issue date Sep 10, 2024
- Merck Patent GmbH
- Matthew Bleich
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Substituted tetrahydrofurans as modulators of sodium channels
- Patent number 11,919,887
- Issue date Mar 5, 2024
- Vertex Pharmaceuticals Incorporated
- Steven John Durrant
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Substituted tetrahydrofurans as modulators of sodium channels
- Patent number 11,834,441
- Issue date Dec 5, 2023
- Vertex Pharmaceuticals Incorporated
- Steven John Durrant
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
N-(hydroxyalkyl (hetero)aryl) tetrahydrofuran carboxamides as modul...
- Patent number 11,827,627
- Issue date Nov 28, 2023
- Vertex Pharmaceuticals Incorporated
- Elizabeth Mary Beck
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Compounds useful as inhibitors of ATR kinase
- Patent number 11,370,798
- Issue date Jun 28, 2022
- Vertex Pharmaceuticals Incorporated
- Nadia Ahmad
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Compounds useful as inhibitors of ATR kinase
- Patent number 11,117,900
- Issue date Sep 14, 2021
- Vertex Pharmaceuticals Incorporated
- Nadia Ahmad
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
GCN2 inhibitors and uses thereof
- Patent number 10,988,477
- Issue date Apr 27, 2021
- Merck Patent GmbH
- Andrew Bayly
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Substituted pyrazines as ATR kinase inhibitors
- Patent number 10,961,232
- Issue date Mar 30, 2021
- Vertex Pharmaceuticals Incorporated
- Jean-Damien Charrier
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Processes for preparing ATR inhibitors
- Patent number 10,822,331
- Issue date Nov 3, 2020
- Vertex Pharmaceuticals Incorporated
- Jean-Damien Charrier
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
GCN2 inhibitors and uses thereof
- Patent number 10,793,563
- Issue date Oct 6, 2020
- Merck Patent GmbH
- Matthew Bleich
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Compounds useful as inhibitors of ATR kinase
- Patent number 10,787,452
- Issue date Sep 29, 2020
- Vertex Pharmaceuticals Incorporated
- Nadia Ahmad
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Substituted pyrazin-2-amines as inhibitors of ATR kinase
- Patent number 10,479,784
- Issue date Nov 19, 2019
- Vertex Pharmaceuticals Incorporated
- Jean-Damien Charrier
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Processes for preparing ATR inhibitors
- Patent number 10,435,397
- Issue date Oct 8, 2019
- Vertex Pharmaceuticals Incorporated
- Jean-Damien Charrier
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Compounds useful as inhibitors of ATR kinase
- Patent number 10,392,391
- Issue date Aug 27, 2019
- Vertex Pharmaceuticals Incorporated
- Nadia Ahmad
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Processes for preparing ATR inhibitors
- Patent number 10,208,027
- Issue date Feb 19, 2019
- Vertex Pharmaceuticals Incorporated
- Jean-Damien Charrier
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Processes for making compounds useful as inhibitors of ATR kinase
- Patent number 9,862,709
- Issue date Jan 9, 2018
- Vertex Pharmaceuticals Incorporated
- Jean-Damien Charrier
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Compounds useful as inhibitors of ATR kinase
- Patent number 9,718,827
- Issue date Aug 1, 2017
- Vertex Pharmaceuticals Incorporated
- Nadia Ahmad
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Substituted pyrazines as ATR kinase inhibitors
- Patent number 9,701,674
- Issue date Jul 11, 2017
- Vertex Pharmaceuticals Incorporated
- Jean-Damien Charrier
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Compounds useful as inhibitors of ATR kinase
- Patent number 9,663,519
- Issue date May 30, 2017
- Vertex Pharmaceuticals Incorporated
- Jean-Damien Charrier
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Compounds useful as inhibitors of ATR kinase
- Patent number 9,650,381
- Issue date May 16, 2017
- Vertex Pharmaceuticals Incorporated
- Nadia Ahmad
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Compounds useful as inhibitors of ATR kinase
- Patent number 9,630,956
- Issue date Apr 25, 2017
- Vertex Pharmaceuticals Incorporated
- Jean-Damien Charrier
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Substituted pyrazin-2-amines as inhibitors of ATR kinase
- Patent number 9,365,557
- Issue date Jun 14, 2016
- Vertex Pharmaceuticals Incorporated
- Jean-Damien Charrier
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Compounds useful as inhibitors of ATR kinase
- Patent number 9,340,546
- Issue date May 17, 2016
- Vertex Pharmaceuticals Incorporated
- Nadia Ahmad
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Compounds useful as inhibitors of ATR kinase
- Patent number 9,334,244
- Issue date May 10, 2016
- Vertex Pharmaceuticals Incorporated
- Jean-Damien Charrier
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Substituted pyrrolo[2,3-b]pyrazines as ATR kinase inhibitors
- Patent number 9,309,250
- Issue date Apr 12, 2016
- Vertex Pharmaceuticals Incorporated
- Pierre-Henri Storck
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Compounds useful as inhibitors of ATR kinase
- Patent number 9,096,584
- Issue date Aug 4, 2015
- Vertex Pharmaceuticals Incorporated
- Jean-Damien Charrier
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Substituted pyrrolo[2,3-B]pyrazines as ATR kinase inhibitors
- Patent number 9,096,602
- Issue date Aug 4, 2015
- Vertex Pharmaceuticals Incorporated
- Simon Everitt
- C07 - ORGANIC CHEMISTRY

Patents Applicationslast 30 patents

Information Patent Application
GCN2 INHIBITORS AND USES THEREOF
- Publication number 20250059190
- Publication date Feb 20, 2025
- Merck Patent GmbH
- Matthew Bleich
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
N-(HYDROXYALKYL (HETERO)ARYL) TETRAHYDROFURAN CARBOXAMIDE ANALOGS A...
- Publication number 20240400544
- Publication date Dec 5, 2024
- VERTEX PHARMACEUTICALS INCORPORATED
- Elizabeth Mary BECK
- C07 - ORGANIC CHEMISTRY
Information Patent Application
SUBSTITUTED TETRAHYDROFURANS AS MODULATORS OF SODIUM CHANNELS
- Publication number 20240391907
- Publication date Nov 28, 2024
- VERTEX PHARMACEUTICALS INCORPORATED
- Steven John Durrant
- C07 - ORGANIC CHEMISTRY
Information Patent Application
SUBSTITUTED TETRAHYDROFURAN-2-CARBOXAMIDES AS MODULATORS OF SODIUM...
- Publication number 20240368135
- Publication date Nov 7, 2024
- VERTEX PHARMACEUTICALS INCORPORATED
- Elizabeth Mary BECK
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
HYDROXY AND (HALO)ALKOXY SUBSTITUTED TETRAHYDROFURANS AS MODULATORS...
- Publication number 20240294512
- Publication date Sep 5, 2024
- VERTEX PHARMACEUTICALS INCORPORATED
- Elizabeth Mary BECK
- C07 - ORGANIC CHEMISTRY
Information Patent Application
N-(HYDROXYALKYL (HETERO)ARYL) TETRAHYDROFURAN CARBOXAMIDES AS MODUL...
- Publication number 20240182455
- Publication date Jun 6, 2024
- VERTEX PHARMACEUTICALS INCORPORATED
- Elizabeth Mary Beck
- C07 - ORGANIC CHEMISTRY
Information Patent Application
SUBSTITUTED TETRAHYDROFURANS AS MODULATORS OF SODIUM CHANNELS
- Publication number 20230286961
- Publication date Sep 14, 2023
- VERTEX PHARMACEUTICALS INCORPORATED
- Steven John Durrant
- C07 - ORGANIC CHEMISTRY
Information Patent Application
COMPOUNDS USEFUL AS INHIBITORS OF ATR KINASE
- Publication number 20230271963
- Publication date Aug 31, 2023
- VERTEX PHARMACEUTICALS INCORPORATED
- Nadia Ahmad
- C07 - ORGANIC CHEMISTRY
Information Patent Application
COMPOUNDS USEFUL AS INHIBITORS OF ATR KINASE
- Publication number 20230030414
- Publication date Feb 2, 2023
- VERTEX PHARMACEUTICALS INCORPORATED
- Jean-Damien Charrier
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
GCN2 INHIBITORS AND USES THEREOF
- Publication number 20220340577
- Publication date Oct 27, 2022
- Merck Patent GmbH
- Andrew BAYLY
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
SUBSTITUTED TETRAHYDROFURANS AS MODULATORS OF SODIUM CHANNELS
- Publication number 20210198241
- Publication date Jul 1, 2021
- VERTEX PHARMACEUTICALS INCORPORATED
- Steven John Durrant
- C07 - ORGANIC CHEMISTRY
Information Patent Application
COMPOUNDS USEFUL AS INHIBITORS OF ATR KINASE
- Publication number 20210047333
- Publication date Feb 18, 2021
- VERTEX PHARMACEUTICALS INCORPORATED
- Nadia AHMAD
- C07 - ORGANIC CHEMISTRY
Information Patent Application
GCN2 INHIBITORS AND USES THEREOF
- Publication number 20210040083
- Publication date Feb 11, 2021
- Merck Patent GmbH
- Matthew Bleich
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
COMPOUNDS USEFUL AS INHIBITORS OF ATR KINASE
- Publication number 20200140441
- Publication date May 7, 2020
- VERTEX PHARMACEUTICALS INCORPORATED
- Nadia Ahmad
- C07 - ORGANIC CHEMISTRY
Information Patent Application
GCN2 INHIBITORS AND USES THEREOF
- Publication number 20190233425
- Publication date Aug 1, 2019
- Merck Patent GmbH
- Andrew Bayly
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
GCN2 INHIBITORS AND USES THEREOF
- Publication number 20190233411
- Publication date Aug 1, 2019
- Merck Patent GmbH
- Matthew Bleich
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
PROCESSES FOR PREPARING ATR INHIBITORS
- Publication number 20190202818
- Publication date Jul 4, 2019
- VERTEX PHARMACEUTICALS INCORPORATED
- Jean-Damien Charrier
- C07 - ORGANIC CHEMISTRY
Information Patent Application
COMPOUNDS USEFUL AS INHIBITORS OF ATR KINASE
- Publication number 20190047995
- Publication date Feb 14, 2019
- VERTEX PHARMACEUTICALS INCORPORATED
- Jean-Damien CHARRIER
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
PROCESSES FOR PREPARING ATR INHIBITORS
- Publication number 20180244662
- Publication date Aug 30, 2018
- VERTEX PHARMACEUTICALS INCORPORATED
- Jean-Damien Charrier
- C07 - ORGANIC CHEMISTRY
Information Patent Application
COMPOUNDS USEFUL AS INHIBITORS OF ATR KINASE
- Publication number 20180170922
- Publication date Jun 21, 2018
- VERTEX PHARMACEUTICALS INCORPORATED
- Jean-Damien Charrier
- C07 - ORGANIC CHEMISTRY
Information Patent Application
COMPOUNDS USEFUL AS INHIBITORS OF ATR KINASE
- Publication number 20180155346
- Publication date Jun 7, 2018
- VERTEX PHARMACEUTICALS INCORPORATED
- Nadia Ahmad
- C07 - ORGANIC CHEMISTRY
Information Patent Application
COMPOUNDS USEFUL AS INHIBITORS OF ATR KINASE
- Publication number 20180072735
- Publication date Mar 15, 2018
- Nadia Ahmad
- C07 - ORGANIC CHEMISTRY
Information Patent Application
COMPOUNDS USEFUL AS INHIBITORS OF ATR KINASE
- Publication number 20160347754
- Publication date Dec 1, 2016
- VERTEX PHARMACEUTICALS INCORPORATED
- Nadia Ahmad
- C07 - ORGANIC CHEMISTRY
Information Patent Application
COMPOUNDS USEFUL AS INHIBITORS OF ATR KINASE
- Publication number 20160326180
- Publication date Nov 10, 2016
- VERTEX PHARMACEUTICALS INCORPORATED
- Dean Boyall
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
COMPOUNDS USEFUL AS INHIBITORS OF ATR KINASE
- Publication number 20160311809
- Publication date Oct 27, 2016
- VERTEX PHARMACEUTICALS INCORPORATED
- Jean-Damien Charrier
- C07 - ORGANIC CHEMISTRY
Information Patent Application
COMPOUNDS USEFUL AS INHIBITORS OF ATR KINASE
- Publication number 20160271129
- Publication date Sep 22, 2016
- VERTEX PHARMACEUTICALS INCORPORATED
- Jean-Damien Charrier
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
COMPOUNDS USEFUL AS INHIBITORS OF ATR KINASE
- Publication number 20160009723
- Publication date Jan 14, 2016
- VERTEX PHARMACEUTICALS INCORPORATED
- Jean-Damien Charrier
- C07 - ORGANIC CHEMISTRY
Information Patent Application
COMPOUNDS USEFUL AS INHIBITORS OF ATR KINASE
- Publication number 20150376187
- Publication date Dec 31, 2015
- VERTEX PHARMACEUTICALS INCORPORATED
- Simon Everitt
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
COMPOUNDS USEFUL AS INHIBITORS OF ATR KINASE
- Publication number 20150299205
- Publication date Oct 22, 2015
- VERTEX PHARMACEUTICALS INCORPORATED
- Jean-Damien Charrier
- C07 - ORGANIC CHEMISTRY
Information Patent Application
COMPOUNDS USEFUL AS INHIBITORS OF ATR KINASE
- Publication number 20150291601
- Publication date Oct 15, 2015
- VERTEX PHARMACEUTICALS INCORPORATED
- Guy Brenchley
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...

Steven Durrant

Person

Patents Grantslast 30 patents

N-(hydroxyalkyl (hetero)aryl) tetrahydrofuran carboxamides as modul...

Substituted tetrahydrofurans as modulators of sodium channels

Compounds useful as inhibitors of ATR kinase

GCN2 inhibitors and uses thereof

Substituted tetrahydrofurans as modulators of sodium channels

Substituted tetrahydrofurans as modulators of sodium channels

N-(hydroxyalkyl (hetero)aryl) tetrahydrofuran carboxamides as modul...

Compounds useful as inhibitors of ATR kinase

Compounds useful as inhibitors of ATR kinase

GCN2 inhibitors and uses thereof

Substituted pyrazines as ATR kinase inhibitors

Processes for preparing ATR inhibitors

GCN2 inhibitors and uses thereof

Compounds useful as inhibitors of ATR kinase

Substituted pyrazin-2-amines as inhibitors of ATR kinase

Processes for preparing ATR inhibitors

Compounds useful as inhibitors of ATR kinase

Processes for preparing ATR inhibitors

Processes for making compounds useful as inhibitors of ATR kinase

Compounds useful as inhibitors of ATR kinase

Substituted pyrazines as ATR kinase inhibitors

Compounds useful as inhibitors of ATR kinase

Compounds useful as inhibitors of ATR kinase

Compounds useful as inhibitors of ATR kinase

Substituted pyrazin-2-amines as inhibitors of ATR kinase

Compounds useful as inhibitors of ATR kinase

Compounds useful as inhibitors of ATR kinase

Substituted pyrrolo[2,3-b]pyrazines as ATR kinase inhibitors

Compounds useful as inhibitors of ATR kinase

Substituted pyrrolo[2,3-B]pyrazines as ATR kinase inhibitors

Patents Applicationslast 30 patents

GCN2 INHIBITORS AND USES THEREOF

N-(HYDROXYALKYL (HETERO)ARYL) TETRAHYDROFURAN CARBOXAMIDE ANALOGS A...

SUBSTITUTED TETRAHYDROFURANS AS MODULATORS OF SODIUM CHANNELS

SUBSTITUTED TETRAHYDROFURAN-2-CARBOXAMIDES AS MODULATORS OF SODIUM...

HYDROXY AND (HALO)ALKOXY SUBSTITUTED TETRAHYDROFURANS AS MODULATORS...

N-(HYDROXYALKYL (HETERO)ARYL) TETRAHYDROFURAN CARBOXAMIDES AS MODUL...

SUBSTITUTED TETRAHYDROFURANS AS MODULATORS OF SODIUM CHANNELS

COMPOUNDS USEFUL AS INHIBITORS OF ATR KINASE

COMPOUNDS USEFUL AS INHIBITORS OF ATR KINASE

GCN2 INHIBITORS AND USES THEREOF

SUBSTITUTED TETRAHYDROFURANS AS MODULATORS OF SODIUM CHANNELS

COMPOUNDS USEFUL AS INHIBITORS OF ATR KINASE

GCN2 INHIBITORS AND USES THEREOF

COMPOUNDS USEFUL AS INHIBITORS OF ATR KINASE

GCN2 INHIBITORS AND USES THEREOF

GCN2 INHIBITORS AND USES THEREOF

PROCESSES FOR PREPARING ATR INHIBITORS

COMPOUNDS USEFUL AS INHIBITORS OF ATR KINASE

PROCESSES FOR PREPARING ATR INHIBITORS

COMPOUNDS USEFUL AS INHIBITORS OF ATR KINASE

COMPOUNDS USEFUL AS INHIBITORS OF ATR KINASE

COMPOUNDS USEFUL AS INHIBITORS OF ATR KINASE

COMPOUNDS USEFUL AS INHIBITORS OF ATR KINASE

COMPOUNDS USEFUL AS INHIBITORS OF ATR KINASE

COMPOUNDS USEFUL AS INHIBITORS OF ATR KINASE

COMPOUNDS USEFUL AS INHIBITORS OF ATR KINASE

COMPOUNDS USEFUL AS INHIBITORS OF ATR KINASE

COMPOUNDS USEFUL AS INHIBITORS OF ATR KINASE

COMPOUNDS USEFUL AS INHIBITORS OF ATR KINASE

COMPOUNDS USEFUL AS INHIBITORS OF ATR KINASE